XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments
3 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, trade accounts and notes receivable and accounts payable. Due to the short-term maturities of cash and cash equivalents, trade accounts and notes receivable and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates. The valuation technique used to measure the fair value of the contingent consideration was based on internal estimates and the use of internal projections of future revenue.

The Company measures its short-term investments and contingent consideration at fair value on a recurring basis.

The following tables present the fair value of the Company’s short-term investments and contingent consideration by valuation hierarchy and input (in thousands):

 

 

 

As of December 31, 2022

 

 

 

Quoted Prices in
Active Markets for
Identical Assets
 (Level 1)

 

 

Significant
Other
Observable
(Level 2)

 

 

Significant
Unobservable
(Level 3)

 

 

Totals

 

 Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

     Corporate bonds

 

$

 

 

$

896

 

 

$

 

 

$

896

 

Total assets

 

$

 

 

$

896

 

 

$

 

 

$

896

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2022

 

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
(Level 2)

 

 

Significant
Unobservable
(Level 3)

 

 

Totals

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

       Corporate bonds

 

$

 

 

$

894

 

 

$

 

 

$

894

 

       Total assets

 

$

 

 

$

894

 

 

$

 

 

$

894

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liabilities:

 

$

 

 

$

 

 

$

175

 

 

$

175

 

Total liabilities

 

$

 

 

$

 

 

$

175

 

 

$

175

 

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the three months ended December 31, 2022 and 2021 (in thousands):

 

Contingent consideration balance at October 1, 2022

$

175

 

Fair value adjustments

 

 

Payment of contingent consideration

 

(175

)

Contingent consideration at December 31, 2022

$

 

 

 

 

Contingent consideration balance at October 1, 2021

$

6,017

 

Fair value adjustments

 

(2,440

)

Payment of contingent consideration

 

(807

)

Contingent consideration balance at December 31, 2021

$

2,770

 

 

Adjustments to the fair value of the contingent consideration were based on internal estimates and management assessments regarding potential future scenarios which involved significant judgment. As of December 31, 2022, the Company had no contingent consideration payable.